Binex Co

Binex Co Net Margin

The Net Profit Margin of Binex Co (053030.KQ) as of Oct 27, 2026 is -1.91 %. In the previous year, Net Profit Margin was -26.97 % — a change of -92.90% (higher).

Net Margin

-1.91 %

YoY

-92.90%

Last updated:

Net Profit Margin of Binex Co is 2025 -1.91 % . Net Profit Margin of Binex Co was 2024 -26.97 % . It decreases by -92.90% higher compared to the previous year.

Binex Co's net margin stands at -1.9%, down from 14.2% several years earlier.

The Binex Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
6.09 KRW
Jan 1, 2019
6.79 KRW
Jan 1, 2020
4.82 KRW
Jan 1, 2021
14.21 KRW
Jan 1, 2022
7.94 KRW
Jan 1, 2023
3.02 KRW
Jan 1, 2024
-26.97 KRW
Jan 1, 2025
-1.91 KRW
The Binex Co Net Margin history
YEARNet MarginYoY
-1.91 %-92.90%
-26.97 %-993.90%
3.02 %-62.02%
7.94 %-44.09%
14.21 %+194.62%
4.82 %-28.97%
6.79 %+11.46%
6.09 %-142.08%
-14.48 %+289.84%
-3.71 %-73.40%
-13.96 %-181.97%
17.03 %-24,082.66%
-0.07 %-212.12%
0.06 %-179.00%
-0.08 %+79.21%
-0.04 %-151.57%
0.09 %+4.77%
0.08 %-4.00%
0.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Net Profit Margin of Binex Co is -1.91 % in 2025.

Net Profit Margin of Binex Co changed from -26.97 % to -1.91 %, representing a -92.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Binex Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Binex Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Binex Co

All Key Metrics — Binex Co